Please login to the form below

Not currently logged in
Email:
Password:

ARX-115

This page shows the latest ARX-115 news and features for those working in and with pharma, biotech and healthcare.

AbbVie to develop argenx-partnered GARP-targeted immunotherapy

AbbVie to develop argenx-partnered GARP-targeted immunotherapy

The biotech can also co-promote ARGX-115-based products in the EU and Swiss Economic Area if it wishes. ... β). The companies have said that ARGX-115 will selectively limit the activity of activated regulatory T-cells (Tregs).

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics